Description: Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. In addition, the company provides technical consultation and services, as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Home Page: www.zyloxtb.com
Zylox-Tonbridge Industrial Park
Hangzhou,
China
Phone:
86 571 8861 0082
Officers
| Name | Title |
|---|---|
| Dr. Zhong Zhao Ph.D. | Founder, Chairman & CEO |
| Mr. Yang Xie | Senior VP of Sales & Marketing and Executive Director |
| Dr. Zheng Li | Senior VP, GM of Neurovascular Business & Executive Director |
| Mr. Quanwei Yuan | CFO & Joint Company Secretary |
| Ms. Sau In Kwan | Joint Company Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 127 |
| Price-to-Book MRQ: | 1.0067 |
| Price-to-Sales TTM: | 0.6722 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 756 |